BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36402749)

  • 1. The role of SPATA2 in TNF signaling, cancer, and spermatogenesis.
    Masola V; Greco N; Tozzo P; Caenazzo L; Onisto M
    Cell Death Dis; 2022 Nov; 13(11):977. PubMed ID: 36402749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
    Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
    EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.
    Wagner SA; Satpathy S; Beli P; Choudhary C
    EMBO J; 2016 Sep; 35(17):1868-84. PubMed ID: 27307491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.
    Wieser V; Tsibulak I; Degasper C; Welponer H; Leitner K; Parson W; Zeimet AG; Marth C; Fiegl H
    Cancer Sci; 2019 Mar; 110(3):1117-1126. PubMed ID: 30697874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
    Elliott PR; Leske D; Hrdinka M; Bagola K; Fiil BK; McLaughlin SH; Wagstaff J; Volkmar N; Christianson JC; Kessler BM; Freund SM; Komander D; Gyrd-Hansen M
    Mol Cell; 2016 Sep; 63(6):990-1005. PubMed ID: 27591049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.
    Wei R; Xu LW; Liu J; Li Y; Zhang P; Shan B; Lu X; Qian L; Wu Z; Dong K; Zhu H; Pan L; Yuan J; Pan H
    Genes Dev; 2017 Jun; 31(11):1162-1176. PubMed ID: 28701375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.
    Kupka S; De Miguel D; Draber P; Martino L; Surinova S; Rittinger K; Walczak H
    Cell Rep; 2016 Aug; 16(9):2271-80. PubMed ID: 27545878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.
    Griewahn L; Müller-Foxworth M; Peintner L; Wissler M; Weiss M; Brauns-Schubert P; Massoumi R; Borner C; Groß O; Yabal M; Charvet C; Maurer U
    Cell Rep; 2023 Jan; 42(1):111961. PubMed ID: 36640323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPATA2: more than a missing link.
    Schlicher L; Brauns-Schubert P; Schubert F; Maurer U
    Cell Death Differ; 2017 Jul; 24(7):1142-1147. PubMed ID: 28282038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of Spata2 by CRISPR/Cas9n causes increased inhibin alpha expression and attenuated fertility in male mice.
    Zhao J; Zhao J; Xu G; Wang Z; Gao J; Cui S; Liu J
    Biol Reprod; 2017 Sep; 97(3):497-513. PubMed ID: 29025062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPATA2: New insights into the assembly of the TNFR signaling complex.
    Schlicher L; Maurer U
    Cell Cycle; 2017 Jan; 16(1):11-12. PubMed ID: 27635695
    [No Abstract]   [Full Text] [Related]  

  • 12. The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells.
    Maran C; Tassone E; Masola V; Onisto M
    Curr Genomics; 2009 Aug; 10(5):361-3. PubMed ID: 20119533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation.
    Wang Y; Wu TR; Cai S; Welte T; Chin YE
    Mol Cell Biol; 2000 Jul; 20(13):4505-12. PubMed ID: 10848577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for FSH-dependent upregulation of SPATA2 (spermatogenesis-associated protein 2).
    Onisto M; Slongo LM; Graziotto R; Zotti L; Negro A; Merico M; Moro E; Foresta C
    Biochem Biophys Res Commun; 2001 Apr; 283(1):86-92. PubMed ID: 11322771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway.
    Marchetti L; Klein M; Schlett K; Pfizenmaier K; Eisel UL
    J Biol Chem; 2004 Jul; 279(31):32869-81. PubMed ID: 15155767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SPATA2/CYLD pathway contributes to doxorubicin-induced cardiomyocyte ferroptosis via enhancing ferritinophagy.
    Zhou YJ; Duan DQ; Lu LQ; Tang LJ; Zhang XJ; Luo XJ; Peng J
    Chem Biol Interact; 2022 Dec; 368():110205. PubMed ID: 36195186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members.
    Vanlangenakker N; Bertrand MJ; Bogaert P; Vandenabeele P; Vanden Berghe T
    Cell Death Dis; 2011 Nov; 2(11):e230. PubMed ID: 22089168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.
    He KL; Ting AT
    Mol Cell Biol; 2002 Sep; 22(17):6034-45. PubMed ID: 12167698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes.
    Urbanik T; Koehler BC; Wolpert L; Elßner C; Scherr AL; Longerich T; Kautz N; Welte S; Hövelmeyer N; Jäger D; Waisman A; Schulze-Bergkamen H
    World J Gastroenterol; 2014 Dec; 20(45):17049-64. PubMed ID: 25493017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.